UUÂãÁÄÖ±²¥

Legal News

Life Sciences weekly highlights—5 December 2024

Published on: 05 December 2024
Published by a
imgtext

Article summary

This week's edition of Life Sciences weekly highlights includes a Law360 analysis on the US FDA’s final guidance on decentralised clinical trials. Also included, is news that the HRA proposed changes to simplify the informed consent process for low-risk clinical trials in the UK, the MHRA announced the selection of five innovative AI technologies for its AI Airlock regulatory sandbox pilot scheme and it issued a final call for marketing authorisation holders to comply with the incoming Windsor Framework arrangements for medicines by 31 December 2024, the ICH launched a consultation on a global multi-regulatory technology platform for the joint assessment of variations to drug licences, MedTech Europe urgently called for reforms to the EU’s medical devices regulatory frameworks, the Association of British HealthTech Industries (ABHI) submitted a comprehensive response to the UK government’s Industrial Strategy Green Paper and news that the EMA revised its Q&A guidance on good manufacturing and distribution practices (GMP/GDP), among other stories.

Popular documents